Patients with postmenopausal osteoporosis showed a significant increase in serum CCL3 compared with other groups, indicating that CCL3 may be a potential biomarker to predict disease severity of postmenopausal osteoporosis (200). The gene discussed is CCL3; the disease is postmenopausal osteoporosis.